Venus Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals

Recent Price Movement and Market Context

On 10 Feb 2026, Venus Remedies closed at ₹713.15, down from the previous close of ₹738.90. The stock traded within a range of ₹705.30 to ₹741.00 during the day, reflecting some volatility but remaining well above its 52-week low of ₹277.85. The 52-week high stands at ₹872.80, indicating significant upside potential from current levels. The day’s decline contrasts with the broader market, where the Sensex has shown modest gains over recent weeks.

Over the short term, Venus Remedies has underperformed the Sensex, with a one-week return of -10.07% compared to the Sensex’s 2.94% gain. However, the stock’s longer-term performance remains impressive, with a one-year return of 98.07% and a ten-year return of 577.90%, far outpacing the Sensex’s respective returns of 7.97% and 249.97%. This disparity highlights the stock’s strong growth trajectory despite short-term fluctuations.

Technical Indicator Analysis: Momentum and Trend Shifts

The technical landscape for Venus Remedies reveals a nuanced picture. The overall technical trend has upgraded from mildly bullish to bullish, signalling increased investor confidence in the stock’s upward potential. Key momentum indicators provide further insight:

• MACD (Moving Average Convergence Divergence): The weekly MACD remains mildly bearish, suggesting some short-term selling pressure. However, the monthly MACD is bullish, indicating that the longer-term momentum is positive and that the recent weakness may be a temporary correction within a broader uptrend.
• RSI (Relative Strength Index): Both weekly and monthly RSI readings currently show no clear signal, hovering in neutral territory. This suggests the stock is neither overbought nor oversold, providing room for a potential upward move without immediate risk of a reversal due to exhaustion.
• Bollinger Bands: Mildly bullish signals on both weekly and monthly charts indicate that price volatility is contained within an upward trending range, supporting the case for continued price appreciation.
• Moving Averages: Daily moving averages are mildly bullish, with the stock price generally trading above key short-term averages. This alignment supports a positive near-term trend.
• KST (Know Sure Thing) Indicator: Both weekly and monthly KST indicators are bullish, reinforcing the momentum shift and suggesting that the stock is gaining strength across multiple timeframes.
• Dow Theory: Confirmed bullish signals on weekly and monthly charts indicate that the stock is in an established uptrend, with higher highs and higher lows being formed.
• OBV (On-Balance Volume): While the weekly OBV shows no clear trend, the monthly OBV is bullish, signalling that buying volume is supporting the price gains over the longer term.

Mojo Score and Grade Update

Venus Remedies currently holds a Mojo Score of 77.0, reflecting a solid technical and fundamental standing within its sector. The Mojo Grade has been adjusted from a Strong Buy to a Buy as of 1 Feb 2026, signalling a slight moderation in conviction but maintaining a positive outlook. The Market Cap Grade is rated 4, indicating a mid-sized market capitalisation relative to peers in the Pharmaceuticals & Biotechnology sector.

This recalibration of the Mojo Grade aligns with the recent price correction and the mixed signals from short-term technical indicators, but the overall trend remains constructive.

Comparative Performance and Sector Context

When benchmarked against the broader Pharmaceuticals & Biotechnology sector and the Sensex, Venus Remedies demonstrates superior long-term growth. Its five-year return of 285.49% significantly outpaces the Sensex’s 63.78%, underscoring the company’s strong operational performance and investor appeal. The three-year return of 377.02% similarly eclipses the Sensex’s 38.25%, highlighting sustained outperformance.

Despite recent short-term underperformance, the stock’s technical indicators suggest that the correction may be a healthy consolidation phase within a larger bullish trend. Investors should note that the sector itself has been experiencing volatility due to regulatory developments and shifting market dynamics, which may have contributed to the recent price softness.

Technical Outlook and Investor Implications

The bullish signals from monthly MACD, KST, and Dow Theory indicators suggest that Venus Remedies is positioned for a potential rebound and continuation of its upward trajectory. The neutral RSI readings imply that the stock is not currently overextended, providing a favourable risk-reward profile for investors considering entry or accumulation.

However, the mildly bearish weekly MACD and lack of clear weekly OBV trend caution that short-term volatility may persist. Traders should monitor key support levels near ₹705 and resistance around ₹740 to gauge momentum shifts. A sustained move above the recent high of ₹741 could confirm renewed buying interest and validate the bullish technical stance.

Overall, the technical parameter changes reflect a positive momentum shift for Venus Remedies, with the stock transitioning into a more confident bullish phase after a period of consolidation. This aligns with the company’s strong fundamentals and sector positioning, making it an attractive candidate for investors with a medium to long-term horizon.

Conclusion: Navigating the Technical Landscape

Venus Remedies Ltd’s recent technical parameter changes indicate a strengthening momentum despite a short-term price setback. The transition from mildly bullish to bullish technical trend, supported by monthly MACD and KST bullishness, suggests that the stock is poised for further gains. Investors should remain mindful of short-term volatility signals but can take comfort in the robust long-term returns and positive sector fundamentals.

With a Mojo Grade of Buy and a strong technical foundation, Venus Remedies remains a compelling option within the Pharmaceuticals & Biotechnology sector. Monitoring key technical levels and volume trends will be essential for timing entries and exits effectively.

Unlock special upgrade rates for a limited period. Start Saving Now →